Sean F. Scanlan
Equibles does not estimate personal net worth.
Get an email with a short summary when Treace Medical Concepts, Inc. publishes a filing, an earnings call transcript or a press release.
Get TMCI alertsAbout Sean F. Scanlan
The proxy statement of Treace Medical Concepts, Inc. reports total compensation of $2,310,894 for Sean F. Scanlan in fiscal 2025, including a base salary of $446,370. Disclosed compensation is on record for 4 fiscal years. Treace Medical Concepts, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Treace Medical Concepts, Inc. includes John Treace (CEO and Board Member), Mark L. Hair (CFO) and Betsy Hanna (Board Member).
Affiliation history
-
Treace Medical Concepts, Inc. (TMCI)
Proxy statement
CurrentStart not stated–present
Last confirmed April 6, 2026
Company network
Leadership on record at Treace Medical Concepts, Inc.
- John Treace CEO, Board Member
- Mark L. Hair CFO
- Betsy Hanna Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Treace Medical Concepts, Inc. (TMCI) | Chief Innovation Officer | $446,370 | $2,310,894 |
| 2024 | Treace Medical Concepts, Inc. (TMCI) | Chief Innovation Officer | $419,262 | $3,085,435 |
| 2023 | Treace Medical Concepts, Inc. (TMCI) | Chief Innovation Officer | $380,630 | $2,949,878 |
| 2022 | Treace Medical Concepts, Inc. (TMCI) | Chief Innovation Officer | $321,370 | $1,338,182 |
Recent activity
No call appearances or filed executive changes recorded yet.